Search research articles
Contact Us
Filters
Showing results (31-40 of 59) with videos related to
Page
of 6
Sort By:
Cancer Research
|
August 3, 2002
The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene
Roberto Diaz, Daniel Ahn, Lluis Lopez-Barcons, et al.
Clinical & Experimental Metastasis
|
January 21, 2012
Subcutaneous passage increases cell aggressiveness in a xenograft model of diffuse large B cell lymphoma
Rosa Bosch, María José Moreno, Rebeca Dieguez-Gonzalez, et al.
International Journal of Nanomedicine
|
March 4, 2025
A Targeted Nanotoxin Inhibits Colorectal Cancer Growth Through Local Tumor Pyroptosis and Eosinophil Infiltration and Degranulation
Luis Miguel Carrasco-Díaz, Alberto Gallardo, Eric Voltà-Durán, et al.
Diagnostics (Basel, Switzerland)
|
June 19, 2024
CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas
Anna C Virgili, Juliana Salazar, Alberto Gallardo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 18, 2021
Antineoplastic effect of a diphtheria toxin-based nanoparticle targeting acute myeloid leukemia cells overexpressing CXCR4
Victor Pallarès, Yáiza Núñez, Laura Sánchez-García, et al.
ACS Materials Letters
|
April 15, 2026
Biomimetic Protein Materials for Adjuvant-Free Dermal Penetration
Marianna T P Favaro, Eric Voltà-Durán, Julieta M Sánchez, et al.
Histopathology
|
January 29, 2014
Focal adhesion protein expression in human diffuse large B-cell lymphoma
Rosa Bosch, Rebeca Dieguez-Gonzalez, María José Moreno, et al.
Haematologica
|
June 29, 2019
A CXCR4-targeted nanocarrier achieves highly selective tumor uptake in diffuse large B-cell lymphoma mouse models
Aïda Falgàs, Victor Pallarès, Ugutz Unzueta, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
April 18, 2016
Cancer-specific uptake of a liganded protein nanocarrier targeting aggressive CXCR4<sup>+</sup> colorectal cancer models
María Virtudes Céspedes, Ugutz Unzueta, Patricia Álamo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 24, 2025
Precision targeting of CXCR4<sup>+</sup> leukemia cells by a humanized MMAE-nanoconjugate in an AML mouse model
Annabel Garcia-León, Julián I Mendoza, Ariana Rueda, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 59) with videos related to
Sort By:
Page
of 6
Cancer Research
|
August 3, 2002
The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene
Roberto Diaz, Daniel Ahn, Lluis Lopez-Barcons, et al.
Clinical & Experimental Metastasis
|
January 21, 2012
Subcutaneous passage increases cell aggressiveness in a xenograft model of diffuse large B cell lymphoma
Rosa Bosch, María José Moreno, Rebeca Dieguez-Gonzalez, et al.
International Journal of Nanomedicine
|
March 4, 2025
A Targeted Nanotoxin Inhibits Colorectal Cancer Growth Through Local Tumor Pyroptosis and Eosinophil Infiltration and Degranulation
Luis Miguel Carrasco-Díaz, Alberto Gallardo, Eric Voltà-Durán, et al.
Diagnostics (Basel, Switzerland)
|
June 19, 2024
CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas
Anna C Virgili, Juliana Salazar, Alberto Gallardo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 18, 2021
Antineoplastic effect of a diphtheria toxin-based nanoparticle targeting acute myeloid leukemia cells overexpressing CXCR4
Victor Pallarès, Yáiza Núñez, Laura Sánchez-García, et al.
ACS Materials Letters
|
April 15, 2026
Biomimetic Protein Materials for Adjuvant-Free Dermal Penetration
Marianna T P Favaro, Eric Voltà-Durán, Julieta M Sánchez, et al.
Histopathology
|
January 29, 2014
Focal adhesion protein expression in human diffuse large B-cell lymphoma
Rosa Bosch, Rebeca Dieguez-Gonzalez, María José Moreno, et al.
Haematologica
|
June 29, 2019
A CXCR4-targeted nanocarrier achieves highly selective tumor uptake in diffuse large B-cell lymphoma mouse models
Aïda Falgàs, Victor Pallarès, Ugutz Unzueta, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
April 18, 2016
Cancer-specific uptake of a liganded protein nanocarrier targeting aggressive CXCR4<sup>+</sup> colorectal cancer models
María Virtudes Céspedes, Ugutz Unzueta, Patricia Álamo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 24, 2025
Precision targeting of CXCR4<sup>+</sup> leukemia cells by a humanized MMAE-nanoconjugate in an AML mouse model
Annabel Garcia-León, Julián I Mendoza, Ariana Rueda, et al.
Page
of 6